Drugs / Mesenchymal stem cells capable of differentiation in the endometrial-decidual direction

Follow last change Dec 2023 re-read 3 minutes ago

Mesenchymal stem cells capable of differentiation in the endometrial-decidual direction

Developed for: pregnancy loss, recurrent, 4
Investigated by: Belarusian Medical Academy of Post-Graduate Education · Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

today NCT05520112 · Ph 1/2

2023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1/2	NCT05520112	Nov 2022 → Dec 2023	pregnancy loss, recurrent, 4	Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Mesenchymal stem cells capable of differentiation in the endometrial-decidual direction	ClinicalTrials.gov intervention name — accepted as the source's own label NCT05520112 ↗
Modality	Cell therapy	“Mesenchymal stem cells capable of differentiation in the endometrial-decidual direction” NCT05520112 ↗